send to a friend by email

JPH reports net income of $2.68 million in H1 2018

2018-09-04

According to the financial statements of Jerusalem Pharmaceuticals JPH for the first half of 2018, Net profit after tax of the period reached 2,680,539 USD Compared with Net profit after tax 3,026,907 USD for 2017, a net decrease in profit of 11.44%.Total assets of the company reached 60,282,882 USD compared with total assets of 61,625,755 USD at the end of year 2017, a net decrease of 2.18%.Total liabilities of the company reached 13,001,634 USD compared with total liabilities of 12,237,751 USD at the end of year 2017, a net increase of 6.24%. Net ownership equity of the company reached 47,281,248 USD (Including Non-Controlling Interests of 815,902 USD) compared with total owner equity of 49,388,004 USD (Including Non-Controlling Interests of 851,077 USD) at the end of year 2017, a net decrease of 4.27%.